Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer.

Arnheim Dahlström L, Andersson K, Luostarinen T, Thoresen S, Ögmundsdottír H, Tryggvadottír L, Wiklund F, Skare GB, Eklund C, Sjölin K, Jellum E, Koskela P, Wadell G, Lehtinen M, Dillner J.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2541-50. doi: 10.1158/1055-9965.EPI-11-0761. Epub 2011 Oct 12.

2.

Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study.

Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H.

Br J Cancer. 2010 May 25;102(11):1665-9. doi: 10.1038/sj.bjc.6605675. Epub 2010 Apr 20.

3.

Is smoking an independent risk factor for invasive cervical cancer? A nested case-control study within Nordic biobanks.

Kapeu AS, Luostarinen T, Jellum E, Dillner J, Hakama M, Koskela P, Lenner P, Löve A, Mahlamaki E, Thoresen S, Tryggvadóttir L, Wadell G, Youngman L, Lehtinen M.

Am J Epidemiol. 2009 Feb 15;169(4):480-8. doi: 10.1093/aje/kwn354. Epub 2008 Dec 13.

PMID:
19074773
4.

Wolcott-Rallison syndrome with 3-hydroxydicarboxylic aciduria and lethal outcome.

Søvik O, Njølstad PR, Jellum E, Molven A.

J Inherit Metab Dis. 2008 Dec;31 Suppl 2:S293-7. doi: 10.1007/s10545-008-0866-1. Epub 2008 May 20.

PMID:
18500571
5.

2-methylbutyryl-CoA dehydrogenase deficiency associated with autism and mental retardation: a case report.

Kanavin OJ, Woldseth B, Jellum E, Tvedt B, Andresen BS, Stromme P.

J Med Case Rep. 2007 Sep 20;1:98.

6.

Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.

Pukkala E, Andersen A, Berglund G, Gislefoss R, Gudnason V, Hallmans G, Jellum E, Jousilahti P, Knekt P, Koskela P, Kyyrönen PP, Lenner P, Luostarinen T, Löve A, Ogmundsdóttir H, Stattin P, Tenkanen L, Tryggvadóttir L, Virtamo J, Wadell G, Widell A, Lehtinen M, Dillner J.

Acta Oncol. 2007;46(3):286-307.

PMID:
17450464
7.

Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S, Jellum E, McColl KE.

Gut. 2007 Jul;56(7):918-25. Epub 2007 Feb 22.

8.

Serum adiponectin is not associated with risk of colorectal cancer.

Lukanova A, Söderberg S, Kaaks R, Jellum E, Stattin P.

Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):401-2. No abstract available.

9.

Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case-control study.

Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, Hakulinen T, Stattin P, Luostarinen T, Lehtinen M, Hakama M.

Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2952-5.

10.
11.

BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case-control study.

Bjørge T, Lie AK, Hovig E, Gislefoss RE, Hansen S, Jellum E, Langseth H, Nustad K, Tropé CG, Dørum A.

Br J Cancer. 2004 Nov 15;91(10):1829-34.

12.

Joint effects of different human papillomaviruses and Chlamydia trachomatis infections on risk of squamous cell carcinoma of the cervix uteri.

Luostarinen T, Lehtinen M, Bjørge T, Abeler V, Hakama M, Hallmans G, Jellum E, Koskela P, Lenner P, Lie AK, Paavonen J, Pukkala E, Saikku P, Sigstad E, Thoresen S, Youngman LD, Dillner J, Hakulinen T.

Eur J Cancer. 2004 May;40(7):1058-65.

PMID:
15093583
13.

Obesity and colon cancer: does leptin provide a link?

Stattin P, Lukanova A, Biessy C, Söderberg S, Palmqvist R, Kaaks R, Olsson T, Jellum E.

Int J Cancer. 2004 Mar;109(1):149-52.

14.

Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation.

Molven A, Matre GE, Duran M, Wanders RJ, Rishaug U, Njølstad PR, Jellum E, Søvik O.

Diabetes. 2004 Jan;53(1):221-7.

15.

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M.

Int J Cancer. 2004 Jan 20;108(3):418-24.

16.

Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer.

Paavonen J, Karunakaran KP, Noguchi Y, Anttila T, Bloigu A, Dillner J, Hallmans G, Hakulinen T, Jellum E, Koskela P, Lehtinen M, Thoresen S, Lam H, Shen C, Brunham RC.

Am J Obstet Gynecol. 2003 Nov;189(5):1287-92.

PMID:
14634555
17.

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries.

Tuohimaa P, Tenkanen L, Ahonen M, Lumme S, Jellum E, Hallmans G, Stattin P, Harvei S, Hakulinen T, Luostarinen T, Dillner J, Lehtinen M, Hakama M.

Int J Cancer. 2004 Jan 1;108(1):104-8.

18.

Capillary electrophoresis with laser-induced fluorescence detection for laboratory diagnosis of galactosemia.

Easley CJ, Jin LJ, Presto Elgstoen KB, Jellum E, Landers JP, Ferrance JP.

J Chromatogr A. 2003 Jul 4;1004(1-2):29-37.

PMID:
12929958
19.

UV-Absorbing compounds in the aqueous humor from aquatic mammals and various non-mammalian vertebrates.

Ringvold A, Anderssen E, Jellum E, Bjerkås E, Sonerud GA, Haaland PJ, Devor TP, Kjønniksen I.

Ophthalmic Res. 2003 Jul-Aug;35(4):208-16.

PMID:
12815196
20.

Plasma leptin is not associated with prostate cancer risk.

Stattin P, Kaaks R, Johansson R, Gislefoss R, Söderberg S, Alfthan H, Stenman UH, Jellum E, Olsson T.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):474-5. No abstract available.

21.

Evaluation of antibody response to human papillomavirus early proteins in women in whom cervical cancer developed 1 to 20 years later.

Lehtinen M, Pawlita M, Zumbach K, Lie K, Hakama M, Jellum E, Koskela P, Luostarinen T, Paavonen J, Pukkala E, Sigstad E, Thoresen S, Dillner J.

Am J Obstet Gynecol. 2003 Jan;188(1):49-55.

PMID:
12548195
22.

Comparison of free amino acids in aqueous humor of farmed and wild salmon and of six species additionally.

Kjønniksen I, Bjerkås E, Jellum E, Ringvold A.

Ophthalmic Res. 2002 Nov-Dec;34(6):366-70.

PMID:
12483024
23.

Herpes simplex virus and risk of cervical cancer: a longitudinal, nested case-control study in the nordic countries.

Lehtinen M, Koskela P, Jellum E, Bloigu A, Anttila T, Hallmans G, Luukkaala T, Thoresen S, Youngman L, Dillner J, Hakama M.

Am J Epidemiol. 2002 Oct 15;156(8):687-92.

PMID:
12370156
24.

A prospective study of the relationship between prediagnostic human papillomavirus seropositivity and HPV DNA in subsequent cervical carcinomas.

Sigstad E, Lie AK, Luostarinen T, Dillner J, Jellum E, Lehtinen M, Thoresen S, Abeler V.

Br J Cancer. 2002 Jul 15;87(2):175-80.

25.

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study.

Bjørge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, Koskela P, Lehtinen M, Pukkala E, Thoresen SØ, Dillner J.

Br J Cancer. 2002 Jul 1;87(1):61-4. Erratum in: Br J Cancer. 2004 Sep 13;91(6):1226.

26.

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M.

Int J Cancer. 2002 May 1;99(1):124-9.

27.

Effect of long-term storage on the concentration of albumin and free fatty acids in human sera.

Høstmark AT, Glattre E, Jellum E.

Scand J Clin Lab Invest. 2001;61(6):443-7.

PMID:
11681533
28.
29.

Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck.

Mork J, Lie AK, Glattre E, Hallmans G, Jellum E, Koskela P, Møller B, Pukkala E, Schiller JT, Youngman L, Lehtinen M, Dillner J.

N Engl J Med. 2001 Apr 12;344(15):1125-31.

30.

Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.

Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikäheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Närvänen A, Pukkala E, Thoresen S, Youngman L, Paavonen J.

JAMA. 2001 Jan 3;285(1):47-51.

PMID:
11150108
31.

Serum organochlorine levels and breast cancer: a nested case-control study of Norwegian women.

Ward EM, Schulte P, Grajewski B, Andersen A, Patterson DG Jr, Turner W, Jellum E, Deddens JA, Friedland J, Roeleveld N, Waters M, Butler MA, DiPietro E, Needham LL.

Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1357-67.

32.

Children with bilateral temporal arachnoid cysts may have glutaric aciduria type 1 (GAT1); operation without knowing that may be harmful.

Lütcherath V, Waaler PE, Jellum E, Wester K.

Acta Neurochir (Wien). 2000;142(9):1025-30.

PMID:
11086812
33.

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries).

Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, Thoresen S, Youngman L, Hakulinen T.

Cancer Causes Control. 2000 Oct;11(9):783-90.

PMID:
11075866
34.

Lipoid proteinosis: high-resolution two-dimensional protein electrophoresis of affected and non-affected skin.

Gjersvik PJ, Thorsrud AK, Jellum E.

Acta Derm Venereol. 2000 May;80(3):230-1. No abstract available.

PMID:
10954231
35.

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer.

Koskela P, Anttila T, Bjørge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J.

Int J Cancer. 2000 Jan 1;85(1):35-9.

36.

Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study.

Hansen S, Melby KK, Aase S, Jellum E, Vollset SE.

Scand J Gastroenterol. 1999 Apr;34(4):353-60.

PMID:
10365894
37.

Serum dehydroepiandrosterone sulfate concentration and thyroid cancer risk: a matched case control study.

Berg JP, Engeland A, Jellum E, Glattre E.

Thyroid. 1999 Mar;9(3):285-8.

PMID:
10211606
38.

No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11.

Luostarinen T, af Geijersstam V, Bjørge T, Eklund C, Hakama M, Hakulinen T, Jellum E, Koskela P, Paavonen J, Pukkala E, Schiller JT, Thoresen S, Youngman LD, Dillner J, Lehtinen M.

Int J Cancer. 1999 Mar 15;80(6):818-22.

39.

Generalized peroxisomal disorder in male twins: fatty acid composition of serum lipids and response to n-3 fatty acids.

Søvik O, Månsson JE, Bjorke Monsen AL, Jellum E, Berge RK.

J Inherit Metab Dis. 1998 Aug;21(6):662-70.

PMID:
9762602
40.

Childhood autism: the need for physical investigations.

Skjeldal OH, Sponheim E, Ganes T, Jellum E, Bakke S.

Brain Dev. 1998 Jun;20(4):227-33.

PMID:
9661967
41.

Capillary electrophoresis for diagnosis of metabolic disease.

Presto Elgstoen KB, Jellum E.

Electrophoresis. 1997 Sep;18(10):1857-60.

PMID:
9372280
42.

Risk for gastric lymphoma in persons with CagA+ and CagA- Helicobacter pylori infection.

Witherell HL, Hansen S, Jellum E, Orentreich N, Vogelman JH, Parsonnet J.

J Infect Dis. 1997 Dec;176(6):1641-4.

PMID:
9395383
43.

Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

Vatten LJ, Ursin G, Ross RK, Stanczyk FZ, Lobo RA, Harvei S, Jellum E.

Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):967-9.

44.

A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway.

Bjørge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, Luostarinen T, Paavonen J, Sapp M, Schiller J, Thoresen S, Wang Z, Youngman L, Dillner J.

Cancer Res. 1997 Sep 15;57(18):3989-92.

45.

Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.

Bjørge T, Dillner J, Anttila T, Engeland A, Hakulinen T, Jellum E, Lehtinen M, Luostarinen T, Paavonen J, Pukkala E, Sapp M, Schiller J, Youngman L, Thoresen S.

BMJ. 1997 Sep 13;315(7109):646-9.

46.

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.

Dillner J, Lehtinen M, Björge T, Luostarinen T, Youngman L, Jellum E, Koskela P, Gislefoss RE, Hallmans G, Paavonen J, Sapp M, Schiller JT, Hakulinen T, Thoresen S, Hakama M.

J Natl Cancer Inst. 1997 Sep 3;89(17):1293-9.

PMID:
9293920
47.

Prediagnostic level of fatty acids in serum phospholipids: omega-3 and omega-6 fatty acids and the risk of prostate cancer.

Harvei S, Bjerve KS, Tretli S, Jellum E, Robsahm TE, Vatten L.

Int J Cancer. 1997 May 16;71(4):545-51.

48.

Diagnostic applications of chromatography and capillary electrophoresis.

Jellum E, Dollekamp H, Brunsvig A, Gislefoss R.

J Chromatogr B Biomed Sci Appl. 1997 Feb 7;689(1):155-64.

PMID:
9061490
49.

Capillary electrophoresis for clinical problem solving: analysis of urinary diagnostic metabolites and serum proteins.

Jellum E, Dollekamp H, Blessum C.

J Chromatogr B Biomed Appl. 1996 Aug 9;683(1):55-65.

PMID:
8876439
50.

Studies on the haemostatic defect in a complicated syndrome. An inverse Scott syndrome platelet membrane abnormality?

Stormorken H, Holmsen H, Sund R, Sakariassen KS, Hovig T, Jellum E, Solum O.

Thromb Haemost. 1995 Nov;74(5):1244-51.

PMID:
8607103

Supplemental Content

Loading ...
Support Center